We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+12.8%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$237M
AUM Growth
-$4.18M
(-1.7%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-7.71%
Top 10 Holdings %
Top 10 Hldgs %
7.93%
Holding
416
New
61
Increased
247
Reduced
47
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.78M |
| 2 |
EOG Resources
EOG
|
+$1.78M |
| 3 |
ConocoPhillips
COP
|
+$1.72M |
| 4 |
Imperial Oil
IMO
|
+$1.64M |
| 5 |
Vornado Realty Trust
VNO
|
+$1.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ryman Hospitality Properties
RHP
|
+$2.57M |
| 2 |
Western Midstream Partners
WES
|
+$2.52M |
| 3 |
INN
Summit Hotel Properties
INN
|
+$2.43M |
| 4 |
Brookfield Renewable
BEPC
|
+$2.38M |
| 5 |
Grupo Aeroportuario del Pacifico
PAC
|
+$2.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.46% |
| 2 | Real Estate | 18.03% |
| 3 | Energy | 13.68% |
| 4 | Materials | 11.34% |
| 5 | Utilities | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
BlackRock Limited Duration Income Trust
BLW
$490M
| $323K | 0.14% |
19,264
+3,424
| +22% | +$54.9K |
|
227
CEL-SCI Corp
CVM
$19.9M
| $323K | 0.14% |
707
+12
| +2% | +$6.55K |
|
228
Akebia Therapeutics
AKBA
$338M
| $320K | 0.14% |
94,432
+1,661
| +2% | +$5.98K |
|
229
Revolution Medicines
RVMD
$38.5B
| $318K | 0.13% |
6,925
+120
| +2% | +$5.38K |
|
230
Scholar Rock
SRRK
$5.88B
| $317K | 0.13% |
6,257
+103
| +2% | +$5.7K |
|
|
NGM
231
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $316K | 0.13% |
10,874
+189
| +2% | +$5.29K |
|
232
BlackRock Floating Rate Income Trust
BGT
$321M
| $315K | 0.13% |
25,200
+3,745
| +17% | +$46.2K |
|
233
Rigel Pharmaceuticals
RIGL
$723M
| $315K | 0.13% |
9,197
+161
| +2% | +$6.38K |
|
234
Relmada Therapeutics
RLMD
$540M
| $315K | 0.13% |
8,947
+164
| +2% | +$5.74K |
|
235
Sutro Biopharma
STRO
$386M
| $314K | 0.13% |
1,381
+23
| +2% | +$5.46K |
|
|
DRNA
236
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $311K | 0.13% |
12,152
+213
| +2% | +$5.44K |
|
237
Acadia Pharmaceuticals
ACAD
$4.51B
| $310K | 0.13% |
12,004
+329
| +3% | +$14.5K |
|
|
AKRO
238
DELISTED
Akero Therapeutics
AKRO
| $303K | 0.13% |
10,454
+178
| +2% | +$5.39K |
|
239
Invesco Senior Income Trust
VVR
$456M
| $303K | 0.13% |
72,233
+7,406
| +11% | +$30.7K |
|
240
BridgeBio Pharma
BBIO
$16.4B
| $302K | 0.13% |
4,902
+82
| +2% | +$5.37K |
|
241
Arcutis Biotherapeutics
ARQT
$3.48B
| $298K | 0.13% |
10,302
+185
| +2% | +$5.78K |
|
|
ARNA
242
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $297K | 0.13% |
4,273
+71
| +2% | +$5.46K |
|
|
SWTX
243
DELISTED
SpringWorks Therapeutics
SWTX
| $295K | 0.12% |
4,006
+66
| +2% | +$5.17K |
|
244
CytomX Therapeutics
CTMX
$690M
| $294K | 0.12% |
38,021
+678
| +2% | +$5.37K |
|
245
Legend Biotech
LEGN
$3.65B
| $291K | 0.12% |
10,016
+182
| +2% | +$4.96K |
|
246
Madrigal Pharmaceuticals
MDGL
$12.6B
| $290K | 0.12% |
2,480
+36
| +1% | +$4.2K |
|
247
Ardelyx
ARDX
$1.24B
| $289K | 0.12% |
43,649
+769
| +2% | +$5.28K |
|
|
SGMO
248
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $288K | 0.12% |
22,950
+396
| +2% | +$5.34K |
|
|
ALLK
249
DELISTED
Allakos
ALLK
| $285K | 0.12% |
2,480
+38
| +2% | +$4.8K |
|
250
Kiniksa Pharmaceuticals
KNSA
$6.23B
| $285K | 0.12% |
15,414
+266
| +2% | +$5.44K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
RC
Virtus ETF Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, Virtus ETF Advisers held 416 positions worth $237M, down 1.7% from $241M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Virtus ETF Advisers withdrew a net $18.3M in Q1 2021, closing 61 positions and reducing 47 holdings. Its most notable exit was Ryman Hospitality Properties, an estimated $2.57M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Real Estate and Energy.
Against the trend, Virtus ETF Advisers opened a new position in Pioneer Natural Resource Co. worth $1.99M.
- Virtus ETF Advisers's largest Q1 2021 buy was Pioneer Natural Resource Co.: 12,538 shares worth $1.99M.
- Virtus ETF Advisers added most to Oaktree Specialty Lending in Q1 2021, an estimated $216K increase.
- Virtus ETF Advisers's biggest Q1 2021 reduction was Avient, cutting an estimated $916K.
- Virtus ETF Advisers fully exited Ryman Hospitality Properties in Q1 2021, selling an estimated $2.57M.
- Virtus ETF Advisers's ten largest holdings make up 7.9% of its $237M portfolio in Q1 2021.
- Virtus ETF Advisers opened 61 new positions and closed 61 in Q1 2021.
- Virtus ETF Advisers's portfolio value fell 1.7% quarter-over-quarter to $237M.
Based on Virtus ETF Advisers's 13F filing for Q1 2021, filed 17 May 2021.